Hologic, Inc.HOLXNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
6.03%
↑ 621% above average
Average (39q)
0.84%
Historical baseline
Range
High:20.57%
Low:-19.44%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 6.03% |
| Q2 2025 | -0.16% |
| Q1 2025 | 1.99% |
| Q4 2024 | -10.40% |
| Q3 2024 | 4.99% |
| Q2 2024 | -14.08% |
| Q1 2024 | 11.68% |
| Q4 2023 | -8.37% |
| Q3 2023 | 0.41% |
| Q3 2023 | -1.89% |
| Q2 2023 | -1.07% |
| Q4 2022 | -1.58% |
| Q3 2022 | 16.74% |
| Q2 2022 | -6.33% |
| Q1 2022 | -4.53% |
| Q4 2021 | -4.84% |
| Q3 2021 | 10.87% |
| Q2 2021 | -3.50% |
| Q1 2021 | 20.57% |
| Q4 2020 | 4.04% |
| Q3 2020 | 3.45% |
| Q2 2020 | 11.76% |
| Q1 2020 | -19.44% |
| Q4 2019 | 1.32% |
| Q3 2019 | -1.63% |
| Q2 2019 | 7.16% |
| Q1 2019 | 7.71% |
| Q4 2018 | 0.95% |
| Q3 2018 | -3.13% |
| Q2 2018 | -4.23% |
| Q1 2018 | 3.65% |
| Q4 2017 | -9.42% |
| Q3 2017 | -3.20% |
| Q3 2017 | 12.82% |
| Q2 2017 | 1.84% |
| Q4 2016 | -12.96% |
| Q3 2016 | 6.29% |
| Q2 2016 | -0.51% |
| Q1 2016 | 14.31% |
| Q4 2015 | -3.90% |